Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Rovi introduces LMW heparin in Spain

Oct. 7, 1998

Candidate gene therapy for hemophilia gives promising results in canine studies

Oct. 5, 1998

Potent, long-acting TxA2 receptor antagonist enters Pfizer development pipeline

Oct. 1, 1998

YM-377 as a treatment for coronary occlusive diseases

Sep. 29, 1998

U.S. patent issues for Bio-Technology General's anticoagulant polypeptide

Sep. 28, 1998

Organon designs nonpeptide thrombin inhibitors mimicking D-Phe-Pro-Arg

Sep. 25, 1998

Controlled clinical trial demonstrates efficacy of cilostazol in intermittent claudication

Sep. 23, 1998

Neutralase preclinical data published; clinical trial still on hold

Sep. 22, 1998

Astra describes SAR leading to antithrombotic agent with novel mechanism of action

Sep. 18, 1998

Sanofi/BMS antiplatelet agent introduced in U.K.

Sep. 17, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 9, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...